Innovative Strategy from UVA Aims at Aggressive Brain Tumor

Buzzline

At the University of Virginia, scientists have created a groundbreaking treatment utilizing targeted ultrasound, microbubbles, and nanoparticles to transport microRNAs through the blood-brain barrier, focusing on several genes implicated in glioblastoma. This form of brain cancer is the most prevalent and aggressive malignant tumor in adults, leading to over 13,000 fatalities each year in the U.S. Preclinical trials in animals demonstrated reduced tumor progression and enhanced survival rates. These results may pave the way for upcoming clinical trials and contribute to the development of novel therapies for brain cancer and other neurological disorders.

Transcript

00:00A new experimental treatment could offer hope against one of the deadliest brain cancers.

00:05Researchers at the University of Virginia are testing a new way to treat glioblastoma.

00:10The method uses focused ultrasound, tiny bubbles, and nanoparticles to reach the brain.

00:15It briefly opens the blood-brain barrier so therapeutic microRNAs can enter.

00:20These microRNAs are designed to switch off multiple genes that fuel tumor growth.

00:25In animal studies, the treatment slowed tumor growth and improved survival.

00:31Glioblastoma is the most common and aggressive malignant brain tumor in adults.

00:35It claims more than 13,000 lives every year in the United States.

00:40The treatment still requires further research before human clinical trials.

00:44Scientists hope this approach could lead to better treatments for brain cancer in the future.

Category

Transcript

Comments

Recommended